<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EDAF9688-F468-467B-9024-433291AFE684"><gtr:id>EDAF9688-F468-467B-9024-433291AFE684</gtr:id><gtr:name>Italian Foundation for Cancer Research</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0F15002C-C70C-4AD9-B432-E950F6B2FDFD"><gtr:id>0F15002C-C70C-4AD9-B432-E950F6B2FDFD</gtr:id><gtr:name>European Institute of Oncology</gtr:name><gtr:address><gtr:line1>Via Ripamonti 435</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Blizard Institute of Cell and Molecular</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EDAF9688-F468-467B-9024-433291AFE684"><gtr:id>EDAF9688-F468-467B-9024-433291AFE684</gtr:id><gtr:name>Italian Foundation for Cancer Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0F15002C-C70C-4AD9-B432-E950F6B2FDFD"><gtr:id>0F15002C-C70C-4AD9-B432-E950F6B2FDFD</gtr:id><gtr:name>European Institute of Oncology</gtr:name><gtr:address><gtr:line1>Via Ripamonti 435</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/33621F13-55E6-49C8-A26F-003792C3DAFB"><gtr:id>33621F13-55E6-49C8-A26F-003792C3DAFB</gtr:id><gtr:firstName>Silvia</gtr:firstName><gtr:surname>Marino</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1F3CB87A-CB26-4345-8EF4-D0CFC1018B95"><gtr:id>1F3CB87A-CB26-4345-8EF4-D0CFC1018B95</gtr:id><gtr:firstName>Axel</gtr:firstName><gtr:surname>Behrens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800020"><gtr:id>A8D4C5AD-D825-464F-9552-72664E46A9AC</gtr:id><gtr:title>Molecular dissection of c-Myc function in self renewal/differentiation of neural stem cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800020</gtr:grantReference><gtr:abstractText>Recent discoveries in cell biology have shown that genes previously implicated in a variety of forms of cancer are also key regulators of the proliferation of normal stem cells. Various signals instruct cells whether to grow or to stop and become a particular cell type. These signals are crucial for proper organ function because the formation of a specific organ depends on the right amount of cell growth being balanced with the right ratio of cells forming differentiated and specialised cells.
 
Here we will focus on brain stem cells and we will perform experiments to examine the function of particular genes, c-Myc and Bmi1, in regulating basic stem cell properties, such as proliferation/self renewal and differentiation. We hope these studies will provide insight into how neural stem cells are regulated during brain development and in neurogenic area of the adult brain.

Understanding how specific genes promote the proliferation of neural stem cells will allow us to set the basis for a potential future development of new treatments for currently incurable brain diseases and injuries.</gtr:abstractText><gtr:technicalSummary>In this proposal, we want to test the hypothesis that the molecular mechanisms that were originally identified to govern c-Myc function in tumourigenesis, also regulate its physiological function in stem cells. 

We will use a combined in vitro and in vivo neural stem cell model to address this question. We will take advantage of a unique set of genetically modified mice, which are either already available in our laboratories or which will be generated in the context of this grant application. In particular we plan to generate compound mutant mice overexpressing c-Myc and the Polycomb group gene Bmi1, to assess whether these two genes act synergistically in controlling self renewal and differentiation of subventricular zone neural stem cell. Moreover a combination of genome-wide gene expression analysis and a systematic approach to identify the set of promoters bound by c-Myc and Bmi-1 will be performed on normal and transgenic SVZ stem cells to identify unknown effectors of neural stem cell biological functions. 

Understanding the molecular mechanisms regulating the biological properties of neural stem cells is crucial for a potential future development of new therapeutic strategies for brain diseases and injuries, which are currently characterised by a dismal prognosis.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-30</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>394114</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Institute of Oncology (IEO)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>c-Myc dataset</gtr:description><gtr:id>AF5258D7-D495-4868-98A9-8823CA05F8CB</gtr:id><gtr:impact>The project is still on going and there are no outputs yet, but the results are expected to be submitted for publication in 2016.</gtr:impact><gtr:outcomeId>56d97d597f77e3.78626913-1</gtr:outcomeId><gtr:partnerContribution>They have helped in comparison of our gene signature with their ChIPSeq/RNASeq data.</gtr:partnerContribution><gtr:piContribution>We identified a gene signature in human choroid plexus tumours expressing high levels of cMyc</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Epigenome of neural stem cells and glioblastoma</gtr:description><gtr:id>3AD252FF-A7D1-4202-9813-F2CFFA234AE2</gtr:id><gtr:impact>Centre of excellence award by the charity Brain Tumour Research, &amp;pound;3,300,000 over 5 years.</gtr:impact><gtr:outcomeId>54622b38d166a9.70791919-1</gtr:outcomeId><gtr:partnerContribution>Access to tissue and primary cells
Essential knowledge</gtr:partnerContribution><gtr:piContribution>Hypothesis to be tested
Essential reagents and knowledge
Leadership of the project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Sciences Centre (CSC)</gtr:department><gtr:description>Epigenome of NSC</gtr:description><gtr:id>75BA6D2B-1C05-4CC2-BB8E-53E948A7E962</gtr:id><gtr:impact>Ongoing, no outputs yet</gtr:impact><gtr:outcomeId>nVNJSxxs3hj-1</gtr:outcomeId><gtr:partnerContribution>Access to facilities,
Sharing unpublished data
Bioinformatics expertise</gtr:partnerContribution><gtr:piContribution>Hypothesis to be tested
Unique reagents
Design of experimental plan</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts Cancer Institute</gtr:department><gtr:description>Drug screening for high grade glioma</gtr:description><gtr:id>FBA119FE-C5C9-4ACE-9F9F-20D012DCD44A</gtr:id><gtr:impact>&amp;pound;192k funding from Barts and The Lodnon Charity</gtr:impact><gtr:outcomeId>MUhMJAdK4KR-1</gtr:outcomeId><gtr:partnerContribution>Hypothesis to be tested
Screening tools</gtr:partnerContribution><gtr:piContribution>Charaterisation of human primary glioma cells
Analysis of xenografts
Pathological expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Italian Foundation for Cancer Research</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>FIRC Institute of Molecular Oncology Foundation</gtr:department><gtr:description>Regulation of survivin by Bmi1</gtr:description><gtr:id>DD0173CA-744E-4EBF-8D77-1B10C7D392DD</gtr:id><gtr:impact>Joint grant application 
Publication: PMID: 23132836</gtr:impact><gtr:outcomeId>qJK5RpxMzjH-1</gtr:outcomeId><gtr:partnerContribution>Sharing of reagents (constructs and mouse models).</gtr:partnerContribution><gtr:piContribution>Hypothesis to be tested
Unique reagents
Design of experimental plan</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological and Chemical Science QMUL</gtr:department><gtr:description>Nanoparticles as drug delivery tool to stem cells</gtr:description><gtr:id>52377A99-7571-4F24-BADC-F0E60C74096E</gtr:id><gtr:impact>&amp;pound;27k award over 6 months from EPSRC/QM</gtr:impact><gtr:outcomeId>r6D8WPTREVN-1</gtr:outcomeId><gtr:partnerContribution>Expertise in nanoparticles
Hypothesis to be tested
Design of experiments</gtr:partnerContribution><gtr:piContribution>Expertise in neural stem cell biology
Hypothesis to be tested
Design of experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>CRUK Multicentre Accelerator Award</gtr:description><gtr:id>07D8D3E3-7936-4F52-BAC2-307ACEC7A4E1</gtr:id><gtr:impact>No output yet, collaboration just started.</gtr:impact><gtr:outcomeId>58c67ba24810b2.67509478-1</gtr:outcomeId><gtr:partnerContribution>I will gain access to tumour samples and cell lines generated and characterised through the consortium, my research team and I will attend research meetings and profit from the overall expertise and resources of the consortium. We will link to the bioinformatics hub to be established by the consortium.</gtr:partnerContribution><gtr:piContribution>I have contributed to the writing of the application as a named collaborator, I will contribute my clinical neuropathological knowledge and my scientific expertise in brain tumour biology to the consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Nanoparticles as drug delivery tool to stem cells</gtr:description><gtr:id>A2AD2DA3-9865-4B21-BDA4-316EF591795F</gtr:id><gtr:impact>&amp;pound;27k award over 6 months from EPSRC/QM</gtr:impact><gtr:outcomeId>r6D8WPTREVN-2</gtr:outcomeId><gtr:partnerContribution>Expertise in nanoparticles
Hypothesis to be tested
Design of experiments</gtr:partnerContribution><gtr:piContribution>Expertise in neural stem cell biology
Hypothesis to be tested
Design of experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Cell Biology Unit</gtr:department><gtr:description>Epigenome of NSC</gtr:description><gtr:id>170609E2-3120-4B3C-A711-20107E524FB6</gtr:id><gtr:impact>Ongoing, no outputs yet</gtr:impact><gtr:outcomeId>nVNJSxxs3hj-2</gtr:outcomeId><gtr:partnerContribution>Access to facilities,
Sharing unpublished data
Bioinformatics expertise</gtr:partnerContribution><gtr:piContribution>Hypothesis to be tested
Unique reagents
Design of experimental plan</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>National Pathology Year Event</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>796681CA-6C22-433A-A719-EF6497DE5131</gtr:id><gtr:impact>Stalls representing Clinical Biochemistry, Haematology, Immunology, Virology and Histopathology gave staff, patients and the general public an opportunity to speak to professionals in each discipline and even to try their hand at some Pathology tests. 


Increase interest of the the general public in Pathology</gtr:impact><gtr:outcomeId>jLVsE9uiL8t</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SPARKS Site visit</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CC080517-E166-4C73-B0B7-A1C1B527011B</gtr:id><gtr:impact>Lay representatives of the charity visited our lab and were shown results of our research

The charity was very impressed with our achievements</gtr:impact><gtr:outcomeId>pyfDty9TZPJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lay presentation at Ataxia UK Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>601C8889-FC46-4A68-8E75-99251B370E6C</gtr:id><gtr:impact>&amp;gt;50 people attended the event

lively discussion after my talk with many questions</gtr:impact><gtr:outcomeId>KE4ru8oWmWX</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Various activities to raise awareness of brain tumour research</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0B03025E-361B-4C4D-9313-65FEFE44B98F</gtr:id><gtr:impact>4 Lab tours with ~20 attendees, attendance to parliamentary events organised by charities, attendance to fundraising events</gtr:impact><gtr:outcomeId>56d59d12beec81.83822991</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media Coverage of the Launch of the BTR Centre of excellence</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9609D650-F13D-444F-AEC5-3530F941424F</gtr:id><gtr:impact>TV and radio interviews

Received many emails form patients, carers and general public</gtr:impact><gtr:outcomeId>546235bd7b4ae6.44225879</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with fundraiser, patients and interested member of the public</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A45ACB47-182B-40A4-956F-92562C2B9E1A</gtr:id><gtr:impact>I estimate approximately 80 people attended the meeting, the discussion was lively, several questions were asked after the talk and at the reception after the talk.

Further similar activities are planned</gtr:impact><gtr:outcomeId>jkL9QD4Cu14</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Centre of The Cell - Contribution</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D258FFBB-88AD-431D-BBD8-924C59D1B22A</gtr:id><gtr:impact>My group,including staff funded by his grant, regularly contributes mateirla, such as slides, cartoons etc. to Centre of the Cell. Centre of the Cell is custom-made, interactive environment in which scientists can efficiently discuss and debate their research with young people.

This is a combination of digital technologies and real-world science that creates a science education experience not available in the classroom.</gtr:impact><gtr:outcomeId>A9igfRBbMsp</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>635000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project grant scheme</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>02145ADD-3B9B-486B-909D-A9A6A866541F</gtr:id><gtr:outcomeId>56d5a3a9dbebb7.06209868</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>57641</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>1year Clinical Research Training Fellowship for a neurosurgery trainee</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Royal College of Surgeons of England</gtr:fundingOrg><gtr:id>12FC504A-EE4E-42D1-806B-A7BD793C8B94</gtr:id><gtr:outcomeId>bTZQpCMcsQC0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>27000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pump Priming Fund</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>767198E2-C106-44F5-9170-56C16BFF9DD4</gtr:id><gtr:outcomeId>n4eE8ZDh3Z8</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>43789</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Training Fellowship for a neuropathology trainee</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Mason Medical Research Foundation</gtr:fundingOrg><gtr:id>8C0042BC-2183-4CF3-8734-819772D7B97D</gtr:id><gtr:outcomeId>56d59b4b019986.56366003</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>85000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C0EC2FB4-CE26-4928-9717-82AA6F9CF763</gtr:id><gtr:outcomeId>ardCRZCv82S</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Brain Tumour Research Centre of Excellence</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>Brain Tumour Research</gtr:fundingOrg><gtr:id>467B50EA-8FAD-4D17-87A7-B410B80B5B99</gtr:id><gtr:outcomeId>5457eb93d1a8f0.55904625</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>192000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Barts Charity</gtr:fundingOrg><gtr:id>BA799C7F-5696-42BD-B1C0-3479DA495A21</gtr:id><gtr:outcomeId>ZyTHf4aN9HN</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>195000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2year Clinical Research Training Fellowship for a neurosurgery trainee</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Sparks</gtr:fundingOrg><gtr:id>9BA6A471-23A2-415A-BC93-99DDB020BDC8</gtr:id><gtr:outcomeId>nc8i3Q5F2GJ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>373000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Postdoctoral Fellowship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Children with Cancer UK</gtr:fundingOrg><gtr:id>5E5FACDC-FBF7-40D9-87AA-A931C91F8571</gtr:id><gtr:outcomeId>54622c3ab14cd4.84288018</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>246281</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/BTC Clinical Research Training Fellowship to a neuropathology trainee (Marino Supervisor)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>The Brain Tumour Charity</gtr:fundingOrg><gtr:id>AE53E404-273B-4422-9A85-554B0CDC5B0F</gtr:id><gtr:outcomeId>58c6734e52de87.51054525</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Small Grant Scheme for a neuropathology trainee</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Pathological Society of Great Britain &amp; Ireland</gtr:fundingOrg><gtr:id>60F4130F-DDAF-4D9C-A988-9D026450C163</gtr:id><gtr:outcomeId>56d59bebc3b167.10956723</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>266500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC CRTF for a neuropathology trainee</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CEBE2159-79EE-435B-A318-ECB7BCA5FC1A</gtr:id><gtr:outcomeId>Eo3kWhij7QL</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Vice-President of the British Neuro-oncology Society</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>814CE1EE-6505-4512-A0E1-DD26E51885CA</gtr:id><gtr:outcomeId>H2AmhkdQyUi</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the scientific committee European Association for Neuro-Oncology</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>529CB792-61A1-45AD-B8AB-48E8F6E53818</gtr:id><gtr:outcomeId>5457ed58c31365.93940328</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Scientific Advisory Board - Children with Cancer UK</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F0698E46-0F5A-4EAC-A4F1-F2082A619C0B</gtr:id><gtr:impact>Impact as above achieved by providing appropriate funding for research project to advance treatment and for clinical initiative for patients benefit.</gtr:impact><gtr:outcomeId>aY1msR9oJi2</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Neuropathology Society Academic Committee Chair</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A3DF8369-9A53-4CAB-9663-33F38EB5352A</gtr:id><gtr:outcomeId>Pdc768eid1F</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Council Member NCRI Clinical Study Group Brain</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9C5B2EC1-B33E-4399-B025-19A2F4151E6D</gtr:id><gtr:outcomeId>5457edaeb049b6.10910271</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Neuro-Oncology Society Council Member</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0701D3FB-FF6A-41B7-A1AF-7655159B8B7F</gtr:id><gtr:outcomeId>hVLri9Apg6w</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chair Scientific Advisory Board Children with Cancer UK</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DD081FB9-C5B6-42C3-B0E6-AE333260AAC6</gtr:id><gtr:impact>I am the chair of a SAB which allocates funding to young medical postgraduate trainees to gain and refine skills in all aspects of childhood cancer.</gtr:impact><gtr:outcomeId>58c6768ec8b410.53615771</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>All-Party Brain Tumour Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CE29CB54-E52D-4921-A54B-356E4B93DAC6</gtr:id><gtr:outcomeId>Rhvjcw6dnXa</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Lead NIHR Integrated Academic Clinical Training at QMUL</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>219E262B-1E24-4380-B56C-1475EEB70FB0</gtr:id><gtr:outcomeId>56d5a4501200b5.47158424</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New mouse line allowing to overexpress c-Myc in a conditional fashion</gtr:description><gtr:id>9FB00477-DBC8-44B0-9BD4-7F623ACCA3AE</gtr:id><gtr:impact>This is a unique tool, which will allow to model and understand the function of c-Myc in normal cells and cancer.</gtr:impact><gtr:outcomeId>BuTHDx8LnNy</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>c-Myc conditional overexpressing mouse line</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Whole genome trascriptomic datasets deposited in openly accessible repositories</gtr:description><gtr:id>B70ECB55-0378-4DEA-9C85-045DB4F4B706</gtr:id><gtr:impact>Facilitate meta-analysis of research data</gtr:impact><gtr:outcomeId>GKcvfTi6Fxe</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Trascriptomic datasets</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F44F0B5A-88A3-4808-9E51-3C2F223AB133</gtr:id><gtr:title>Epigenetic regulation of survivin by Bmi1 is cell type specific during corticogenesis and in gliomas.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32794abb5c8d39efad080deb89266678"><gtr:id>32794abb5c8d39efad080deb89266678</gtr:id><gtr:otherNames>Acquati S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_15821_21_23132836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC1C5937-918C-4432-8B5A-848A5AE19A65</gtr:id><gtr:title>Conditional activation of Bmi1 expression regulates self-renewal, apoptosis, and differentiation of neural stem/progenitor cells in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0927fa7f3aee1b94a8c6c77fc020b861"><gtr:id>0927fa7f3aee1b94a8c6c77fc020b861</gtr:id><gtr:otherNames>Yadirgi G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>K9UwW2bU4eL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>698549FD-E656-4CEA-B052-E2BDD8FBE007</gtr:id><gtr:title>ROLE OF C-MYC IN CHOROID PLEXUS TUMOURS</gtr:title><gtr:parentPublicationTitle>NEURO-ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7087a3eebb18865076f6ae3933679aa"><gtr:id>a7087a3eebb18865076f6ae3933679aa</gtr:id><gtr:otherNames>Merve Ashirwad</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1522-8517</gtr:issn><gtr:outcomeId>58c12b1ee21ea8.26762409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FFF2571-3838-41E0-80A8-2FD670CBD876</gtr:id><gtr:title>Inactivation of the ATMIN/ATM pathway protects against glioblastoma formation.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8e4bdea6dff28802374fade2e9d8fc8"><gtr:id>e8e4bdea6dff28802374fade2e9d8fc8</gtr:id><gtr:otherNames>Blake SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>58a6c8e30a2009.89572283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ECD9874-87D4-4B71-90B9-480B52408093</gtr:id><gtr:title>Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b1b24a187dfbc8fce8f94d8cd01b870"><gtr:id>0b1b24a187dfbc8fce8f94d8cd01b870</gtr:id><gtr:otherNames>Guillotin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn><gtr:outcomeId>58a6c8e2b52bd6.38044950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5163972-394F-4D25-A328-80D819412E6E</gtr:id><gtr:title>Fluorescent polymeric nanovehicles for neural stem cell modulation.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8293f3b2f8ae2dde967623ba7bff0ff"><gtr:id>c8293f3b2f8ae2dde967623ba7bff0ff</gtr:id><gtr:otherNames>Papadimitriou SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>58a6c8e2dee8d1.90081837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B65B2B5-99FC-4B9A-9876-CC646C9A01FD</gtr:id><gtr:title>c-Myc in choroid plexus tumourigenesis</gtr:title><gtr:parentPublicationTitle>NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eebfaae634daabd4d608234d88fcad8"><gtr:id>0eebfaae634daabd4d608234d88fcad8</gtr:id><gtr:otherNames>Merve A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>58c12b1e96d1e6.94568111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11FA4A17-6747-4AB3-B7AF-F22B743CF468</gtr:id><gtr:title>Consensus Paper: Cerebellar Development.</gtr:title><gtr:parentPublicationTitle>Cerebellum (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08fbe05cf24506b9ce00c60941b8a718"><gtr:id>08fbe05cf24506b9ce00c60941b8a718</gtr:id><gtr:otherNames>Leto K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1473-4222</gtr:issn><gtr:outcomeId>56d599c4ba4d32.19915930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C8F8B14-6EDD-46AF-A17E-DD593D0DD802</gtr:id><gtr:title>OP10 * ROLE OF C-MYC IN CHOROID PLEXUS TUMOURS</gtr:title><gtr:parentPublicationTitle>Neuro-Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1da85a7d0adbe10822422856d632f8"><gtr:id>9d1da85a7d0adbe10822422856d632f8</gtr:id><gtr:otherNames>Merve A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>58c681df3d2bd1.78661982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DB9ABCB-7FB4-475A-9A6C-2769D34F13B2</gtr:id><gtr:title>Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7faca2fd216fd0494bb95dad707bbe63"><gtr:id>7faca2fd216fd0494bb95dad707bbe63</gtr:id><gtr:otherNames>Hoeck JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>aeSH7qW922j</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800020</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>